| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |